Search

everythinglearnresearchcommunity

for

Search:↓

More adolescent girls in urban areas of India have Polycystic Ovary Syndrome compared to those in rural areas.

Acne is an important sign of androgen excess disorders in women.

The N363S gene variant does not cause higher adrenal androgen levels in women with polycystic ovary syndrome.

Women with PCOS in Sicily show different levels of metabolic problems depending on their PCOS type, with obesity and abnormal lipid profiles being common.

Treating hirsutism in women often requires a mix of medications and cosmetic methods for best results.

Treating excessive hair in women requires a holistic approach, including medical, aesthetic, and emotional support.

Alfacalcidiol and metformin together lowered testosterone in women with PCOS, but did not significantly improve acne, hair growth, or pregnancy rates.

Hibiscus petals helped control blood sugar and improve liver and pancreas health in diabetic rats.

Insulin resistance is not more common in idiopathic hirsutism patients than in healthy individuals.

PSA levels are higher in women with PCOS, but FAI is a more accurate marker for diagnosis.

Ayurvedic Panchakarma therapy, Virechan, can effectively manage PCOS symptoms and improve health markers.

Higher testosterone levels in Nigerian women with PCOS are linked to glucose disorders like diabetes.

There is no significant link between insulin resistance and certain hair disorders like idiopathic hirsutism and androgenic alopecia.

Hair loss is a common but often unreported side effect of cancer treatments, especially for breast and prostate cancers.

Hair loss is a common side effect of hormone treatments for cancer.

Hair loss is a common, often overlooked side effect of hormone treatments for breast and prostate cancer.

Hyperthyroidism can hide signs of high androgen levels in females.

Exposure to fatty acids significantly increased androgen levels in female dogs, suggesting a link to conditions like insulin resistance and PCOS.

Anti-IL-1 treatments might help with certain types of hair loss in people with high inflammation.

Blocking IL-1 could help treat some hair loss conditions; alopecia affects liver detox systems; spironolactone is better than finasteride for female hair growth; focusing on the catagen hair phase could lead to new alopecia treatments.

Alopecia patients have a less active liver monoxygenase system, which can be treated with photochemotherapy and system inducers.

Spironolactone is more effective than finasteride in treating excessive hair growth in women.

Excessive hair growth in women can be treated with medications like spironolactone and finasteride, and male-pattern baldness in women can be improved with similar treatments.

Higher doses of oestradiol implants improve bone density in postmenopausal women.

Long-term use of oral contraceptives, especially starting before age 20, may increase the risk of early-onset breast cancer.

Women with PCOS should be screened for heart disease risk and manage their health to prevent it.

The hypothesis suggests that PCOS may start early in life due to genetic and environmental factors, influencing future reproductive and metabolic problems.

Myo-inositol supplements may improve insulin sensitivity and help with conditions like PCOS and gestational diabetes, but more research is needed.

Chemicals and body size might change when puberty starts and progresses, but more research is needed to confirm this.

Creating stronger blockers for skin enzymes might lead to better treatment for conditions like acne and excessive hair growth.